HomeBXMPY • OTCMKTS
add
Beximco Pharmaceuticals GDR
Market news
Financials
Income Statement
Revenue
Net income
| (BDT) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 12.30B | — |
Operating expense | 3.17B | — |
Net income | 1.83B | — |
Net profit margin | 14.88 | — |
Earnings per share | — | — |
EBITDA | 2.91B | — |
Effective tax rate | 23.11% | — |
Balance Sheet
Total assets
Total liabilities
| (BDT) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.85B | — |
Total assets | 73.80B | — |
Total liabilities | 20.17B | — |
Total equity | 53.63B | — |
Shares outstanding | 446.11M | — |
Price to book | — | — |
Return on assets | 8.29% | — |
Return on capital | 10.14% | — |
Cash Flow
Net change in cash
| (BDT) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 1.83B | — |
Cash from operations | 1.04B | — |
Cash from investing | -1.56B | — |
Cash from financing | 1.32B | — |
Net change in cash | 795.91M | — |
Free cash flow | 1.09B | — |
About
Founded
1976
Headquarters
Website
Employees
1,122
